A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/16/2011	EP2386314A1 Vaccines against chlamydial infection
11/16/2011	EP2386313A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
11/16/2011	EP2386312A2 Intrathecal and intratumoral superantigens to treat malignant disease
11/16/2011	EP2385981A1 Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
11/16/2011	EP2385980A1 Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
11/16/2011	EP2385955A2 Modified antibody compositions, methods of making and using thereof
11/16/2011	EP2385843A1 Treatment of mucositis with kallikrein inhibitors
11/16/2011	EP2385842A1 Cna_b domain antigens in vaccines against gram positive bacteria
11/16/2011	EP2049154B1 Plasmid with immunological action
11/16/2011	EP2029627B1 Hepatocyte growth factor (hgf) binding proteins
11/16/2011	EP1937712B1 Polynucleotides of haemophilus parasuis and its use
11/16/2011	EP1901768B1 Methods of modulating il-23 activity; related reagents
11/16/2011	EP1740205B1 Preventive vaccination against melanoma
11/16/2011	EP1646657B1 Antibodies to cd44 vra and methods of use
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	EP1019439B1 Soluble single-chain t-cell receptor proteins
11/16/2011	CN1944644B Process for preparing HIV-lgp120 and human gamma-interferon fusion protein
11/16/2011	CN1874790B Therapeutic agent for mesothelioma
11/16/2011	CN1311820B BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses
11/16/2011	CN102246045A Biomarkers and methods for detecting and treating spinal and joint pain
11/16/2011	CN102245773A Antibodies that specifically block the biological activity of a tumor antigen
11/16/2011	CN102245641A High affinity human antibodies to PCSK9
11/16/2011	CN102245640A Anti-PD-L1 antibodies and their use to enhance T-cell function
11/16/2011	CN102245639A Antibody formulation
11/16/2011	CN102245638A Antibodies against IL-25
11/16/2011	CN102245629A Modified amyloid beta peptide
11/16/2011	CN102245208A Immunoglobulin variants and uses thereof
11/16/2011	CN102245207A Humanized anti-IL-6 antibodies
11/16/2011	CN102245206A Method for obtaining an excipient-free antibody solution
11/16/2011	CN102245205A Methods to reduce B-helper T cells to treat autoimmune diseases
11/16/2011	CN102245204A Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents
11/16/2011	CN102245203A Combined influenza vaccines for seasonal and pandemic protection
11/16/2011	CN102245202A Vaccine compositions comprising a mutated factor h binding protein
11/16/2011	CN102245201A Adjuvant incorporation in immunonanotherapeutics
11/16/2011	CN102245200A Nicotine immunonanotherapeutics
11/16/2011	CN102245199A Targeting of antigen presenting cells with immunonanotherapeutics
11/16/2011	CN102245198A IgE CH3 peptide vaccine
11/16/2011	CN102245197A Vaccine for the prevention of breast cancer recurrence
11/16/2011	CN102242150A Heat shock protein-GP96 (HSP-GP96) recombinant adenovirus vector and construction method and application thereof
11/16/2011	CN102242132A Enterovirus 71 capsid protein 1 antigen, preparation method and immunodetection reagent
11/16/2011	CN102242131A Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof
11/16/2011	CN102242122A Nucleic acid aptamer specifically combined with HCV (hepatitis C virus) non-structural protein NS2, and application thereof
11/16/2011	CN102242083A 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I
11/16/2011	CN102241776A RANKL-TNF (Receptor Activator of Nuclear Factor Kappa-B Ligand-Tumour Necrosis Factor) sample region fusion protein and preparation method and application thereof
11/16/2011	CN102241774A Recombinant IgE-Fc-anti EGFR single chain variable fragment fusion protein, its preparation method and its application
11/16/2011	CN102241773A Anti-myeloma cell polyclonal antibody and preparation method thereof
11/16/2011	CN102241770A Influenza virus M2-targeted ion channel protein VHH (Vibrio Harveyi Haemolysin) gene engineering antibody and coding gene and application thereof in preparation of anti-influenza-virus drug
11/16/2011	CN102241769A Binding molecules capable of neutralizing rabies virus and uses thereof
11/16/2011	CN102241768A Antibody against hemagglutinin of influenza A H1N1 virus
11/16/2011	CN102241758A Preparation method and medical application of cervical carcinoma associated trichina antigen antibody
11/16/2011	CN102240404A Vibrio harveyi DNA vaccine and its construction method and application
11/16/2011	CN102240402A Method for preparing chicken genetic engineering immunopotentiator by akirin2 gene sequence
11/16/2011	CN102240401A New application of hepatitis A attenuated live vaccine in prevention and treatment of asthma
11/16/2011	CN102240400A Method for producing rabies vaccine by applying bioreactor and sheet carrier
11/16/2011	CN102240399A Application of siniperca chuatsi ISKNV (Infectious Spleen and Kidney Necrosis Virus) ORF093 protein
11/16/2011	CN102240398A Edwardsiella tarda subunit vaccine and preparation method thereof
11/16/2011	CN101933909B Vaccine adjuvant effervescent tablet and preparation method thereof
11/16/2011	CN101838317B Mimic short peptide 11B of endothelial cell growth factor VEGF antigen epitope and application thereof
11/16/2011	CN101838310B Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
11/16/2011	CN101690811B Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
11/16/2011	CN101676301B Antibody for inhibiting growth of colorectal carcinoma and its use in preparation of medicament and kit
11/16/2011	CN101654482B High specific anti-tumor monoclonal antibody
11/16/2011	CN101480492B Combined inactivated vaccine for against infectious brunchitis and newcastle disease and preparation method thereof
11/16/2011	CN101429234B Vaccine based on simulating human blood vessel endothelial cell growth factor VEGF epitope and preparation method thereof
11/16/2011	CN101422607B Peste des petis ruminants recombined goat pox virus movable carrier vaccine
11/16/2011	CN101385855B Fine purification method of polyvalent anti-snake venom freeze-dry blood serum
11/16/2011	CN101351477B Anti-CD19 antibodies with reduced immunogenicity
11/16/2011	CN101348525B Anti-schistosomiasis monoclonal antibody NP11-4 single-chain antibody, preparation and use thereof
11/16/2011	CN101274963B Anti-cd86 humanized monoclonal antibody
11/16/2011	CN101204582B Multivalent hepatitis B fusion protein targeted adjuvant vaccine, preparation method and uses thereof
11/16/2011	CN101144062B Lactobacillus casei strain and application for products thereof in bird immunity
11/16/2011	CN101128182B Heavy chain and domain antibodies
11/16/2011	CN101012454B Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058407 Purification of acidic proteins using ceramic hydroxyapatite chromatography
11/15/2011	US8058406 Composition comprising antibodies to LINGO or fragments thereof
11/15/2011	US8058405 Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
11/15/2011	US8058401 Immunogenic compositions and uses thereof
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058254 DNA vaccines encoding heat shock proteins
11/15/2011	US8058251 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058226 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability
11/15/2011	US8058050 Cellular permissivity factor for viruses and uses thereof
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8058012 Five-helix protein
11/15/2011	US8057816 Compositions and methods of administering paclitaxel with other drugs using medical devices
11/15/2011	US8057809 Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
11/15/2011	US8057808 Use of a botulinum neurotoxin to alleviate various disorders
11/15/2011	US8057807 Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
11/15/2011	US8057806 Viruses comprising mutant ion channel protein
11/15/2011	US8057805 Edwardsiella ictaluri E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
11/15/2011	US8057804 Herpes simplex virus combined subunit vaccines and methods of use thereof
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057798 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 1823